Sangeeta Ghosh Spruce Biosciences

Dr. Sangeeta Ghosh has 19 years of drug development experience that spans all phases of drug development and includes FDA regulatory approval of Gocovri, Intermezzo, and other drugs. She is currently the Vice President, Pharmaceutical Development and Manufacturing at Spruce Biosciences. Before joining Spruce in 2018, Dr. Ghosh served as Vice President at Adamas Pharmaceuticals, before which, she had leadership roles at Transcept Pharmaceuticals and Anthera Pharmaceuticals. She started drug development at ALZA Corporation, a Johnson & Johnson Company. Dr. Ghosh conducted post-doctoral researcher at the University of Florida and Universite Louis Pasteur at Strasbourg. She earned her Ph.D. in molecular biophysics and synthetic organic chemistry from IISc Bangalore and her M.Sc. degree in chemistry from IIT Kanpur.